News

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after infection clears.
We’re not intending to capture all possible patients, but those we think would make the best trial candidates so that we can ...
Join Drs Ginette Okoye and Rebecca Manno as they discuss the connection between HS and arthritis, practice pearls, and novel ...
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...
This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...
I am 77 and have crusty patches on my breasts, back and stomach. Could they be cancerous? Dr Ellie Cannon replies: It is ...
I often saw the vagus nerve when operating, at the base of the brain or in the neck – a small, insignificant thing, the width ...
More than 1.7 million people over state pension age across Great Britain will receive up to £1,362 each month through a ...
The opioid crisis has made it even more urgent to come up with novel approaches to treating suffering. Finally there’s ...
Approaching the age his dad was when he died at Daytona, a second-generation legend went looking for answers. I went looking, ...
HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...
WHEN it comes to issues of obesity, there is no doubt that so-called fat jabs have turned the tide on treatment options. Even ...